Home - Products - Others - Other Targets - 1-O-trans-caffeoyl-5-O-trans-p-coumaroylquinicacid

1-O-trans-caffeoyl-5-O-trans-p-coumaroylquinicacid

CAS No. 1401532-34-0

1-O-trans-caffeoyl-5-O-trans-p-coumaroylquinicacid( ——— )

Catalog No. M39706 CAS No. 1401532-34-0

1-O-trans-caffeoyl-5-O-trans-p-coumaroylquinicacid

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    1-O-trans-caffeoyl-5-O-trans-p-coumaroylquinicacid
  • Note
    Research use only, not for human use.
  • Brief Description
    1-O-trans-caffeoyl-5-O-trans-p-coumaroylquinicacid
  • Description
    1-O-trans-caffeoyl-5-O-trans-p-coumaroylquinicacid
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1401532-34-0
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Diamide

    Diamide is a reagent used as a thiol oxidizing agent.

  • Thymosin β4 (human, ...

    Thymosin β4 (human, bovine, horse, rat)

  • (R)-Omeprazole Sodiu...

    (R)-Omeprazole (sodium) (Standard) is the analytical standard of (R)-Omeprazole (sodium). This product is intended for research and analytical applications. (R)-Omeprazole sodium is a gastric acid resistant compound with activity to inhibit gastric acid secretion. (R)-Omeprazole sodium is metabolized in vivo, and its metabolism is primarily affected by cytochrome P450 enzymes. The interaction between (R)-Omeprazole sodium and mannitol may affect its bioavailability in formulations. (R)-Omeprazole sodium exhibits reversible direct and metabolism-dependent inhibition of CYP2C19.